Cediranib (RECENTIN)

cediranib · AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cediranib (RECENTIN), covering 2012-09-06 to 2012-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Cediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell Carcinoma [Phase 2]